IL17A and pulmonary fibrosis: Il17 and Ifnγ have been reported to exert opposing effects on the development of pulmonary fibrosis [50-53] and a predictive model based on their interaction supports the paradigm that fibrotic lung disease is the result of the synergy between various immune cell types and their cytokine repertoires [54].